Skip to content
10-Q

Quarterly Report

REMEDENT, INC.

0001104659-20-021920

← back to feed
Filed
Feb 14, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Feb 14, 2020 20M sh
Cash And Equivalents Q3 2020 · Dec 31, 2019 $101.55K
Cash And Equivalents Q3 2020 · Mar 31, 2019 $66.54K
Stockholders Equity Q3 2020 · Dec 31, 2019 $4.89M
Stockholders Equity Q3 2020 · Mar 31, 2019 $5.39M
Current Liabilities Q3 2020 · Dec 31, 2019 $2.7M
Current Liabilities Q3 2020 · Mar 31, 2019 $2.43M
Total Liabilities Q3 2020 · Dec 31, 2019 $2.79M
Total Liabilities Q3 2020 · Mar 31, 2019 $2.43M
Current Assets Q3 2020 · Dec 31, 2019 $768.21K
Current Assets Q3 2020 · Mar 31, 2019 $655.93K
Total Assets Q3 2020 · Dec 31, 2019 $7.76M
Total Assets Q3 2020 · Mar 31, 2019 $7.9M
Rd Expense Q3 2020 · Dec 31, 2019 $0
Rd Expense Q3 2020 · Dec 31, 2019 $0
Rd Expense Q3 2020 · Dec 31, 2018 $0
Rd Expense Q3 2020 · Dec 31, 2018 $120
Shares Diluted Q3 2020 · Dec 31, 2018 20M sh
Shares Diluted Q3 2020 · Dec 31, 2018 20M sh
Operating Cash Flow Q3 2020 · Dec 31, 2018 −$21.95K
Eps Diluted Q3 2020 · Dec 31, 2018 −$0.01
Eps Diluted Q3 2020 · Dec 31, 2018 −$0.02
Eps Basic Q3 2020 · Dec 31, 2018 −$0.01
Eps Basic Q3 2020 · Dec 31, 2018 −$0.02
Sga Expense Q3 2020 · Dec 31, 2018 $270.2K
Sga Expense Q3 2020 · Dec 31, 2018 $713.03K
Net Income Q3 2020 · Dec 31, 2018 −$187.75K
Net Income Q3 2020 · Dec 31, 2018 −$422.67K
Operating Income Q3 2020 · Dec 31, 2018 −$222.38K
Operating Income Q3 2020 · Dec 31, 2018 −$491.61K
Gross Profit Q3 2020 · Dec 31, 2018 $273.79K
Gross Profit Q3 2020 · Dec 31, 2018 $832.21K
Cost Of Revenue Q3 2020 · Dec 31, 2018 $145.54K
Cost Of Revenue Q3 2020 · Dec 31, 2018 $367.61K
Revenue Q3 2020 · Dec 31, 2018 $419.33K
Revenue Q3 2020 · Dec 31, 2018 $1.2M